Leading firms sign up for China International Import Expo’s medicine and health exhibition area Release date:2018-06-06

Thermo Fisher Scientific will participate in the in the Medical Equipment and Medicine & Health Care Exhibition Area at the China International Import Expo. The firm’s products span analytical instruments, laboratory equipment, reagents, consumables, and software. In addition, its services cover food safety, environmental protection, medical care, life sciences, and biological pharmacy.

 As the promotion of the exhibition moves forward, multiple leading enterprises have signed up to the Medical Equipment and Medicine & Health Care Exhibition Area. 

The First China International Import Expo provides a “big platform” for foreign medical and health enterprises to gain a foothold in the Chinese market. Increasingly international leading medical and health companies have also targeted the Chinese market. More and more enterprises are signing on to the exhibition area with an increase in display area size. Leading names that have already signed up include AstraZeneca, Roche, Sanofi-Aventis, Bayer, Royal Philips, Johnson & Johnson, Swisse and Elekta.

 The Expo also provides foreign medical and health enterprises with a “new stage” to showcase their new products in China. Elekta will show off its latest magnetic resonance radiation therapy system, Elekta Unity, at the Expo. Elekta Unity is the medical equipment product to combine magnetic resonance and radiotherapy technologies globally. The accuracy rate of cancer therapy can be increased dramatically through its use.

 In addition, the Expo provides a “direct route” for enterprises to serve people in China. Chinese policies have led to increasing benefits. In recent years, the government has been playing an active role in the medical and health industry. The Healthy China strategy is incorporated into the government’s 13th Five-Year Plan. Enterprises are actively registering to participate in the exhibition, while the government will has made it free to import anti-cancer Alkaloid drugs as well as Chinese medicines. The relaxed import environment makes it more convenient to enter the Chinese market. When leading companies like Thermo Fisher Scientific introduce new technologies to China, they can spur on scientific innovations that will better serve one-fifth of the world's population.